Sleep Intervention for Autism Spectrum Disorder
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to assist children with autism spectrum disorder (ASD) who struggle with sleep. Researchers are testing a modified sleep and circadian intervention, designed to improve sleep patterns, to determine its effects on sleep habits, daytime behavior, and parental stress. Children aged 6-12 with ASD who experience issues like difficulty falling asleep or staying asleep may be suitable candidates. Participants will either receive the new intervention or continue with their usual care for 12 weeks. The trial will assess how well these approaches improve sleep and overall quality of life for both children and their parents. As an unphased trial, this study provides a unique opportunity for families to contribute to research that could enhance sleep and quality of life for children with ASD.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, your child should not have had any medication changes in the past month that interfere with sleep.
What prior data suggests that this intervention is safe for children with autism spectrum disorder?
Research has shown that sleep problems are common in children with autism, affecting over 80% of them. These issues can include difficulty falling asleep, staying asleep, or waking up too early. Sleep problems often occur alongside challenges like behavioral issues and anxiety.
The sleep and circadian intervention under study aims to improve various aspects of sleep, such as sleep quality and duration. While specific safety data from previous studies on this exact intervention is unavailable, behavioral sleep interventions are generally considered safe. They typically involve techniques like setting regular sleep schedules and creating bedtime routines, which are non-invasive and have a low risk of side effects.
Even without direct safety data, it is reasonable to believe this type of intervention is well-tolerated. This is especially true because the trial is in an early stage, focusing on safety and feasibility. Behavioral interventions typically pose minimal risk, making them a promising option for helping children with autism improve their sleep.12345Why are researchers excited about this trial?
Researchers are excited about the Modified Sleep and Circadian Intervention for children with Autism Spectrum Disorder because it targets sleep and circadian rhythms directly, unlike most current treatments that often focus on behavioral therapies or medications like melatonin. This approach is unique because it aims to adjust the body's natural sleep-wake cycle, potentially improving overall sleep quality and daily functioning. By aligning sleep patterns more closely with natural circadian rhythms, this intervention could offer a more holistic and less invasive alternative to existing treatments.
What evidence suggests that this modified sleep and circadian intervention is effective for improving sleep in children with autism?
Research has shown that sleep problems are common in children with autism, affecting over 80% of them. Studies have found that behavioral sleep interventions can help children fall asleep and stay asleep more easily, with clear improvements compared to no treatment. In this trial, participants may receive the modified sleep and circadian intervention, designed to tackle various sleep issues, such as bedtime habits, sleep timing, and sleep duration. Early results suggest that these interventions could not only improve sleep but also enhance daytime behavior and overall quality of life for children with autism. By addressing these sleep aspects, the intervention aims to reduce problems like disruptive behavior and stress for parents.12467
Who Is on the Research Team?
Megan L Wenzell, PhD
Principal Investigator
Case Western Reserve University
Are You a Good Fit for This Trial?
This trial is for school-aged children (6-12 years) with a clinical diagnosis of Autism Spectrum Disorder who are not currently in any sleep-related interventions, have at least one poor sleep health dimension, and no recent medication changes affecting sleep. Parents must be proficient in English and legal guardians.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a modified behavioral sleep and circadian intervention for 12 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Modified Sleep and Circadian Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Case Western Reserve University
Lead Sponsor
American Academy of Sleep Medicine
Collaborator
National Institutes of Health (NIH)
Collaborator
National Center for Advancing Translational Sciences (NCATS)
Collaborator
University Hospitals Cleveland Medical Center
Collaborator